Position in NVCT
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$773
+$139 QoQ
Shares Held
100
+19.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Sterling Capital Management LLC holds $38,251,297 across 230 Biotechnology names. NVCT ranks #222 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,738 | $9,841,888 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,338 | $5,955,950 | |
| 3 | ASND |
Ascendis Pharma A/S
|
14,929 | $3,414,710 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
14,615 | $2,762,965 | |
| 5 | INSM |
INSMED Inc
|
12,993 | $2,124,615 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,182 | $1,714,568 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
11,343 | $1,103,106 | |
| 8 | VCEL |
Vericel Corp
|
31,635 | $1,017,697 |
All Filings in NVCT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $773 | 100 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $634 | 84 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $186 | 31 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $231 | 31 | Shares | Sole | 2025-08-08 | |
| No filing history on record for this holder in this stock. | ||||||